Mankind Pharma Limited (BOM:543904)
India · Delayed Price · Currency is INR 2,372.00
-13.00 (-0.55%)
At close: Aug 21, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 984.58 billion as of August 21, 2026. Its market cap has decreased by -4.83% in one year.
Market Cap
984.58B
Enterprise Value
1.03T
Revenue
147.38B
Ranking
n/a
PE Ratio
48.20
Stock Price
2,372.00
ChartMarket Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 984.58B, an increase of 72.81%. That is a compound annual growth rate of 18.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 984.58B | 8.59% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.91T |
| Lupin | 1.02T |
| Dr. Reddy's Laboratories | 975.42B |
| Abbott India | 560.98B |
| GlaxoSmithKline Pharmaceuticals | 513.99B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 297.76B |
| Granules India | 207.68B |